Table 3.
The univariate analysis of inflammatory and nutritional markers
| Situation | Only pre-NACT markers | Only post-NACT markers | Both pre-NACT and post-NACT markers | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-NACT | Post-NACT | Pre-NACT | Post-NACT | Change valueb | |||||||||||
| Adjustment | Age, sex, location, clinical stage | Age, sex, location, post-NACT clinical stage | Age, sex, location, clinical stage | ||||||||||||
| Survival | OS | Post-NACT OS | |||||||||||||
| HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | HR | 95% CI | P | |
| NLR | 1.128 | 0.973 ~ 1.308 | 0.059 | 1.008 | 0.782 ~ 1.264 | 0.994 | 1.127 | 0.972 ~ 1.308 | 0.068 | 1.011 | 0.803 ~ 1.272 | 0.927 | 0.893 | 0.489 ~ 1.630 | 0.711 |
| PLR | 1.002 | 0.998 ~ 1.005 | 0.343 | 1.003 | 0.997 ~ 1.009 | 0.330 | 1.001 | 0.998 ~ 1.005 | 0.387 | 1.003 | 0.997 ~ 1.010 | 0.273 | 0.874 | 0.459 ~ 1.661 | 0.680 |
| LMR | 0.936 | 0.801 ~ 1.094 | 0.408 | 1.141 | 0.966 ~ 1.347 | 0.121 | 0.934 | 0.800 ~ 1.091 | 0.391 | 1.162 | 0.980 ~ 1.378 | 0.084 | 1.202 | 1.029 ~ 1.405 | 0.020 |
| SII | 1.000 | 1.000 ~ 1.001 | 0.078 | 1.000 | 0.999 ~ 1.002 | 0.390 | 1.000 | 1.000 ~ 1.001 | 0.100 | 1.001 | 1.000 ~ 1.002 | 0.275 | 0.948 | 0.479 ~ 1.876 | 0.878 |
| CRPa | 0.961 | 0.854 ~ 1.080 | 0.497 | 0.991 | 0.951 ~ 1.032 | 0.658 | 0.962 | 0.858 ~ 1.079 | 0.513 | 0.991 | 0.950 ~ 1.033 | 0.672 | 1.012 | 0.983 ~ 1.041 | 0.430 |
| CARa | 0.254 | 0.004 ~ 18.29 | 0.530 | 0.631 | 0.116 ~ 3.428 | 0.594 | 0.278 | 0.004 ~ 18.26 | 0.549 | 0.624 | 0.109 ~ 3.581 | 0.596 | 1.773 | 0.472 ~ 6.657 | 0.396 |
| mGPSa | |||||||||||||||
| 0 | Ref | Ref | Ref | Ref | NA | NA | NA | ||||||||
| 1 | 0.231 | 0.017 ~ 3.061 | 0.266 | 0.795 | 0.176 ~ 3.586 | 0.765 | 0.262 | 0.022 ~ 3.116 | 0.289 | 0.793 | 0.177 ~ 3.548 | 0.762 | NA | NA | NA |
| PIa | |||||||||||||||
| 0 | Ref | Ref | Ref | Ref | NA | NA | NA | ||||||||
| 1 | 0.692 | 0.121 ~ 3.958 | 0.679 | 0.654 | 0.147 ~ 2.907 | 0.577 | 0.727 | 0.132 ~ 4.006 | 0.714 | 0.646 | 0.146 ~ 2.854 | 0.564 | NA | NA | NA |
| mSIS | |||||||||||||||
| 0 | Ref | Ref | Ref | Ref | NA | NA | NA | ||||||||
| 1 | 0.819 | 0.332 ~ 2.021 | 0.665 | 0.900 | 0.409 ~ 1.982 | 0.794 | 0.789 | 0.320 ~ 1.948 | 0.608 | 0.986 | 0.451 ~ 2.158 | 0.972 | NA | NA | NA |
| 2 | 1.009 | 0.391 ~ 2.605 | 0.984 | 1.692 | 0.731 ~ 3.923 | 0.220 | 0.966 | 0.374 ~ 2.500 | 0.943 | 1.692 | 0.726 ~ 3.942 | 0.223 | NA | NA | NA |
| Hgb | 0.991 | 0.978 ~ 1.003 | 0.151 | 0.982 | 0.968 ~ 0.997 | 0.015 | 0.990 | 0.978 ~ 1.003 | 0.138 | 0.982 | 0.968 ~ 0.996 | 0.014 | 0.990 | 0.973 ~ 1.008 | 0.286 |
| Alb | 0.980 | 0.910 ~ 1.055 | 0.595 | 0.997 | 0.923 ~ 1.077 | 0.659 | 0.980 | 0.910 ~ 1.054 | 0.581 | 0.977 | 0.906 ~ 1.053 | 0.542 | 0.998 | 0.932 ~ 1.069 | 0.965 |
| BMI | 1.010 | 0.930 ~ 1.100 | 0.811 | 0.982 | 0.892 ~ 1.079 | 0.700 | 1.012 | 0.931 ~ 1.100 | 0.776 | 0.989 | 0.902 ~ 1.084 | 0.816 | 0.839 | 0.659 ~ 1.067 | 0.152 |
| PNI | 0.971 | 0.918 ~ 1.027 | 0.300 | 1.008 | 0.946 ~ 1.074 | 0.805 | 0.971 | 0.918 ~ 1.026 | 0.291 | 1.006 | 0.943 ~ 1.073 | 0.858 | 1.194 | 0.679 ~ 2.098 | 0.538 |
P values are marked in bold if less than 0.1
Alb, albumin; BMI, body mass index; CAR, C-reactive protein–albumin ratio; CI, confidence interval; CRP, C-reactive protein; Hgb, hemoglobin; HR, hazard ratio; LMR, lymphocyte-to-monocyte ratio; mGPS, modified glasgow prognostic score; mSIS, modified systemic inflammation score; NACT, neoadjuvant chemotherapy; NA, not applicable; NLR, neutrophil-to-lymphocyte ratio; OS, overall survival; PI, prognostic index; PLR, platelet-to-lymphocyte ratio; PNI, prognostic nutrition index; ref, reference; SII, systemic immune-inflammation index
aData from 142 pre-NACT patients and 177 post-NACT patients
bChange value was calculated by subtracting the pre-NACT value from the post-NACT value